Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases

INTRODUCTION: Inclusion body myositis (IBM) is a slowly progressive degenerative inflammatory disorder affecting both proximal and distal muscles. Immunosuppressive therapies are generally ineffective in the treatment of this disorder, and most patients are resistant to steroid therapy. Some benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherin, Patrick, Delain, Jean-Christophe, de Jaeger, Christophe, Crave, Jean-Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: November 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649754/
https://www.ncbi.nlm.nih.gov/pubmed/26600787
http://dx.doi.org/10.1159/000441490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649754/
https://www.ncbi.nlm.nih.gov/pubmed/26600787
http://dx.doi.org/10.1159/000441490

Ejemplares similares